Delusional Problems and Mood Instability in Acute Psychotic Patients Dependent to Methamphetamine named Shishe among Iranian Population

Saberi, Seyed Mehdi; Khodabandeh, Farideh; Kahani, Alireza; Marashi, Seyed Mehdi

doi:10.4172/2155-6105.1000132

Search citation statements

Order By: Relevance

Paper Sections

Select...

Psychosis and Intoxication1

Editorial1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2015

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 19 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychotic symptoms, delusions, hallucinations (Saberi et al, 2012), mood instability, disorientation, self-mutilation (Fashipour et al, 2013) Table 1). …”

Section: Psychosis and Intoxicationmentioning

confidence: 99%

Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country

Alammehrjerdi

Mokri

Dolan

2015

Asian Journal of Psychiatry

View full text Add to dashboard Cite

“…Psychotic symptoms, delusions, hallucinations (Saberi et al, 2012), mood instability, disorientation, self-mutilation (Fashipour et al, 2013) Table 1). …”

Section: Psychosis and Intoxicationmentioning

confidence: 99%

Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country

Alammehrjerdi

Mokri

Dolan

2015

Asian Journal of Psychiatry

View full text Add to dashboard Cite

“…He was diagnosed with a first episode of MAP and did not report MAP symptoms in the absence of methamphetamine use but he was treated with six sessions of electroconvulsive therapy (ECT) and prescribing psychiatric medications [17]. A study on 50 methamphetamine abusers recruited from the Iranian legal medical organization in Tehran showed that delusion, mood instability, disorientation, and self-mutilation were prevalent among the patients [18]. …”

Section: Editorialmentioning

confidence: 99%

Methamphetamine-associated psychosis: a new health challenge in Iran

2013

View full text Add to dashboard Cite

The rapidly growing popularity of methamphetamine use in Iran has posed a new health challenge to the Iranian health sector. Methamphetamine-associated psychosis (MAP) has been frequently reported in Iran in recent years. Although methamphetamine use and MAP are considerable health problems in Iran but there is still a need to conduct epidemiological studies on the prevalence of MAP and its health-related problems. The present paper emphasizes that health policy makers should consider the immediate needs of drug users, their families and the community to be informed about the detrimental health effects associated with MAP. Although MAP could be managed by prescribing benzodiazepines and psychiatric medications but the most effective regime for stabilizing patients with MAP still needs to be studied in Iran. Constant collaborations among psychiatric services and outpatient psychotherapeutic services should be established to successfully manage MAP in Iran. Iranian clinicians especially emergency medicine specialists should be informed about the differences between the two forms of transient and recurrent MAP in order to implement appropriate pharmacological therapies to manage MAP. It is hoped that special training courses are designed and implemented by health policy makers to inform clinicians, health providers and especially emergency medicine specialists to effectively deal with MAP.

show abstract

Delusional Problems and Mood Instability in Acute Psychotic Patients Dependent to Methamphetamine named Shishe among Iranian Population

Cited by 2 publications

References 19 publications

Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country

Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country

Methamphetamine-associated psychosis: a new health challenge in Iran

Contact Info

Product

Resources

About